Sky Century Investment (SKYI) Enterprise Value (2012 - 2026)

Sky Century Investment (SKYI) reported Enterprise Value of -$3360.0 for Q1 2026, down 619.49% quarter-over-quarter from -$467.0 in Q4 2025.

Sky Century Investment (SKYI) Enterprise Value (2012 - 2026) Analysis & Trends

Sky Century Investment (SKYI) has 5 years of Enterprise Value data on file, last reported at -$3360.0 in Q1 2026.

Enterprise Value for Q1 2026 came in at -$3360.0, changed N/A year-over-year; the trailing twelve-month figure through Feb 2026 was -$3360.0 (changed N/A YoY), and the FY2025 annual result was -$477.0, changed N/A from the prior year.
Enterprise Value retreated to -$3360.0 in Q1 2026 per SKYI's latest filing, from -$467.0 in the prior quarter.
Over five years, Enterprise Value peaked at -$467.0 in Q4 2025 and troughed at -$11312.0 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Enterprise Value (Qtr)
1	Teva Pharmaceutical Industries	39.72 Bn	35.98 Bn	1.97 Bn	-3.74 Bn
2	Zoetis	34.61 Bn	32.67 Bn	1.62 Bn	-1.94 Bn
3	United Therapeutics	24.07 Bn	21.91 Bn	648.10 Mn	-2.15 Bn
4	Aurora Cannabis	16.98 Bn	16.91 Bn	33.43 Mn	-77.77 Mn
5	Neurocrine Biosciences	16.64 Bn	15.32 Bn	800.70 Mn	-1.32 Bn
6	Elanco Animal Health	12.19 Bn	11.76 Bn	785.00 Mn	-428.00 Mn
7	Alkermes	7.37 Bn	6.86 Bn	-116.06 Mn	-511.86 Mn
8	Hims & Hers Health	6.62 Bn	5.87 Bn	396.79 Mn	-750.88 Mn
9	Lantheus Holdings	6.47 Bn	5.97 Bn	230.92 Mn	-498.58 Mn
10	Sky Century Investment	-	-	31,666.00	-3,360.00

Download Data